CVE-2023-37413: IBM Aspera Faspex

Medium severity, CVSS 5.3. EPSS: 0.3% chance of exploitation in the next 30 days.

IBM Aspera Faspex 5.0.0 through 5.0.10 could disclose sensitive username information due to an observable response discrepancy.

Affected products

• IBM Aspera Faspex: from 5.0.0, up to and including 5.0.10

Published 2025-01-29. Last modified 2026-06-17.